Produits pharmaceutiques & dispositifs médicaux
Featured news
AIM successfully launches its Calculator for Fair Medicines Prices in Europe
The International Association of Mutual Benefit Societies (AIM) has launched today its calculator for fair medicines prices in Europe (German version here). The calculator transposes AIM's fair pricin......
Recommendations towards fair medicines prices in Europe
12 European and international organisations representing not-for-profit healthcare insurers, healthcare professionals, public interest organisations and trade unions have developed and endorsed recomm......
AIM calls for a Pharmaceutical Strategy shaped to ensure and promote solidarity and sustainable healthcare in the European Union
AIM, the International Association of Mutual Benefit Societies, has articulated a set of recommendations to rebalance pharmaceutical markets in Europe. AIM calls for the European Pharmaceutical Str......
Other news
L’AIM fait partie du projet ASCERTAIN qui vise à garantir l’accès des patients européens à des médicaments abordables
L'AIM participe à un projet européen sur l'accessibilité financièr...
Déclaration commune sur la révision de la législation pharmaceutique par les associations représentant les prestataires de soins de santé, les patients, les professionnels de la santé et les payeurs
Améliorer l'accès des patients à des médicaments de haute qualité...
“Better treatment for better health: lifting the veil on treatment optimisation” – Stakeholders exchange views on patient-centred clinical research at EORTC and AIM’s seminar
Treatment optimisation is defined as clinical research in real-world c...
La Commission européenne ouvre sa consultation publique sur la révision de la législation pharmaceutique générale
Le 28 septembre, la Commission européenne a ouvert sa consultation pu...
Payer involvement is important for a successful EU HTA framework!
The International Association of Mutual Benefit Societies (AIM) welcom...
AIM successfully launches its Calculator for Fair Medicines Prices in Europe
The International Association of Mutual Benefit Societies (AIM) has la...
Joint Statement – Transparency is needed to reap the full benefits of the EU’s investment in its Vaccines Strategy
Ahead of Friday 18 September's webinar the EU Vaccine Strategy, a numb...
Recommendations towards fair medicines prices in Europe
12 European and international organisations representing not-for-profi...
AIM calls for a Pharmaceutical Strategy shaped to ensure and promote solidarity and sustainable healthcare in the European Union
AIM, the International Association of Mutual Benefit Societies, has ar...